Race Oncology hopes its repurposed drug candidate bisantrene can protect the heart from the dangerous effect of chemotherapy.

Out of 27 IPOs in 2024, two resources plays, an engineering stock, a Mexican food chain and a wool clothing company topped ...

The second part of our monster list of ASX mining stock picks from fund managers and analysts around Australia.

Key investment 'megatrends' to watch out for in 2025? Geopolitical tensions/rising defence spending, energy demand and AI ...

Arcadium shareholders approve $10 billion takeover by Rio Tinto, with the mining giant hoping to secure its lithium prize by ...

Research firm Allens says more M&A activity is expected in 2025, confirming lithium’s positive long-term outlook.

ASX keeps the rally going on Christmas Eve as Avita jumps, St Barbara tanks. Meanwhile Bitcoin dips but 'altcoins' get some ...

In this episode, host Sarah Hughan recaps the past 12 months for Queensland explorer QMines (ASX:QML) and its impressive ...

Investors have seemingly been taking advantage of pre-Christmas sales, with the ASX 200 closing to the upside by a very ...

QEM snares Coordinated Project status for its Julia Creek vanadium and oil shale project; Leeuwin shareholders like Marda ...

A “valuation disconnect” between groups of larger stocks on the ASX versus their smaller counterparts could give value ...